Item 1.01. Entry into a Material Definitive Agreement.



On January 4, 2022, OrthoPediatrics Corp. (the "Company") entered into a Third
Amendment (the "Amendment") to its Fourth Amended and Restated Loan and Security
Agreement (the "Agreement") among Squadron Capital LLC, a Delaware limited
liability company, the Company, and the other Borrowers (as defined in the
Agreement), dated as of December 31, 2017. The Amendment addresses the
transition of the interest rate calculation from a LIBOR (London Interbank
Offered Rate) based rate to a SOFR (Secured Overnight Financing Rate) based
rate. The previous interest rate on the facilities was at the greater of (a)
three month LIBOR plus 8.61% and (b) 10.0%. Following the Amendment, the
interest rate on the facilities is the greater of (a) six month SOFR plus 8.69%
and (b) 10.0%.

The foregoing description of the Amendment is not complete and is qualified in
its entirety by reference to the Amendment which is filed as Exhibit 10.1 and is
incorporated herein by reference.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth under Item 1.01 above is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description


               10.1           Third Amendment to the Fourth Amended and

Restated Loan Agreement, dated as


                            of December 31, 2021, by and among

OrthoPediatrics Corp., its subsidiaries


                            named therein and Squadron Capital LLC
                104         Cover Page Interactive Data File (embedded

within the Inline XBRL document).





                                  * * * * * *

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses